Identifying Early Predictive Markers for Immune-Related Adverse Events in Nivolumab-Treated Patients with Renal Cell Carcinoma and Gastric Cancer.

Takada, Shinya; Murooka, Hidetaka; Tahatsu, Kanae; Yanase, Maki; Umehara, Kengo; Hashishita, Hirokazu; Toru, Harabayashi; Satoru, Maruyama; Sagawa, Tamotsu; Fujikawa, Koshi; Sato, Hideki; Mino, Kozo

Takada, Shinya; Murooka, Hidetaka; Tahatsu, Kanae; Yanase, Maki; Umehara, Kengo; Hashishita, Hirokazu; Toru, Harabayashi; Satoru, Maruyama; Sagawa, Tamotsu; Fujikawa, Koshi; Sato, Hideki; Mino, Kozo.

Afiliação

Takada S; Department of Pharmacy, National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido, Japan.
Murooka H; Department of Pharmacy, National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido, Japan.
Tahatsu K; Department of Pharmacy, National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido, Japan.
Yanase M; Department of Pharmacy, National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido, Japan.
Umehara K; Department of Pharmacy, National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido, Japan.
Hashishita H; Department of Pharmacy, National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido, Japan.
Toru H; Department of Urology, National Hospital Organization Hokkaido Cancer Center, Japan.
Satoru M; Department of Urology, National Hospital Organization Hokkaido Cancer Center, Japan.
Sagawa T; Department of Gastroenterology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido, Japan.
Fujikawa K; Department of Gastroenterology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido, Japan.
Sato H; Faculty of Pharmaceutical Sciences, Hokkaido University of Science, Hokkaido Japan.
Mino K; Department of Pharmacy, National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido, Japan.

Asian Pac J Cancer Prev ; 23(2): 695-701, 2022 Feb 01.

Article em En | MEDLINE | ID: mdl-35225483

Assuntos

Antineoplásicos Imunológicos/efeitos adversos; Contagem de Células Sanguíneas; Carcinoma de Células Renais/sangue; Neoplasias Renais/sangue; Nivolumabe/efeitos adversos; Neoplasias Gástricas/sangue; Adulto; Idoso; Idoso de 80 Anos ou mais; Biomarcadores Tumorais/sangue; Plaquetas/metabolismo; Carcinoma de Células Renais/tratamento farmacológico; Carcinoma de Células Renais/imunologia; Feminino; Humanos; Neoplasias Renais/tratamento farmacológico; Neoplasias Renais/imunologia; Modelos Logísticos; Linfócitos/metabolismo; Masculino; Pessoa de Meia-Idade; Gradação de Tumores; Neutrófilos/metabolismo; Valor Preditivo dos Testes; Prognóstico; Intervalo Livre de Progressão; Estudos Retrospectivos; Medição de Risco; Fatores de Risco; Neoplasias Gástricas/imunologia; Taxa de Sobrevida

Palavras-chave

Immune checkpoint inhibitors; Neutrophils to lymphocytes; immune-related adverse event; platelet to lymphocytes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Contagem de Células Sanguíneas / Carcinoma de Células Renais / Antineoplásicos Imunológicos / Nivolumabe / Neoplasias Renais Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Asian Pac J Cancer Prev Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google